Review warns of lean mass and vitamin deficits on GLP-1 therapy
Nutrition in Clinical Practice describes reduced meal size, lower water intake, shifts in palatable food and alcohol choice, and reported bone and muscle loss.
MH
By Maren Holt · Senior Reporter, GLP-1
The wire
- 01A narrative review examines how semaglutide, tirzepatide and newer satiety hormone agonists alter hunger, satiety, satiation and reward eating.
- 02Author notes loss of lean tissue including bone and muscle plus reported vitamin deficiencies, arguing nutritional counseling and possible dose adjustment are central to care.
- 03It is a narrative review without pooled estimates, so the frequency and magnitude of deficiencies remain unquantified.
From the source
Read at pubmed.ncbi.nlm.nih.govEffect of GLP-1 receptor agonist on nutrient intake: A narrative review
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026 Sep 17 · Fujioka K et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42754546/